Literature DB >> 29157148

Implementation of clinical pharmacy services in an academic oncology practice in India.

Himanshu Patel1, Parthasarathi Gurumurthy1.   

Abstract

Objective This study was conducted to investigate medication-related problems after implementation of clinical pharmacy services at a speciality oncology care setting. Methods It was a prospective interventional study conducted for a period of three years at a private academic oncology care setting. Paper-based medical records and medication orders were reviewed and patients and care givers were interviewed to understand the treatment plan. All the medication-related problems were identified by clinical pharmacists by performing drug therapy review. Patients were also followed up at ambulatory care and in-patient units to ensure appropriate administration of anti-cancer drugs by nurses. All the medication-related problems were discussed with the concerned clinicians and then were resolved with the interventions of clinical pharmacists. Clinical significance of these interventions were assessed and classified as "Major", "Moderate "and "Minor". Educational, clinical and system-based interventions were developed and implemented to minimize medication-related problems at the study site. Results A total of 1359 medication-related problems were identified from 2120 medication orders reviewed of 1362 patients followed during the study period. The most common medication-related problems were lack of suboptimal supportive care (17.95%), inappropriate administration of medications (14.56%), untreated indication (14.20%), wrong dosing calculations (12.21%), drug-drug interactions (11.62%) and sub-therapeutic dose (11.11%). Clinical pharmacy interventions were made to resolve all the medication-related problems. Clinical significance of majority (n = 504, 37.08%) of medication-related problems was "Moderate" followed by "Major" (n = 434, 31.93%) and "Minor" (n = 421, 30.97%). Conclusion The study has demonstrated the importance of clinical pharmacy services in improving quality and safe use of medicines in oncology practice. Positive feedback of clinicians on clinical pharmacy services was a reflection of acceptance of clinical pharmacy interventions by clinicians.

Entities:  

Keywords:  Cancer care; clinical pharmacists; clinical pharmacy interventions; drug therapy review; oncology pharmacists

Year:  2017        PMID: 29157148     DOI: 10.1177/1078155217739684

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.809


  5 in total

1.  Impact of educational interventions on utilization patterns of anticancer agents in patients with breast cancer at the specialty oncology care setting in South India.

Authors:  Aakanksha Sharma; Himanshu Patel; Gurumurthy Parthasarathi
Journal:  Perspect Clin Res       Date:  2020-12-09

2.  Implementation of clinical pharmacist recommendations and services at a University Hospital in Yemen.

Authors:  Mohammed A Kubas; Abdulsalam M Halboup
Journal:  Int J Clin Pharm       Date:  2019-11-11

3.  Evaluation of Antibiotic Use in Kazakhstan for the Period 2017-2019 Based on WHO Access, Watch and Reserve Classification (AWaRe 2019).

Authors:  Gulzira Zhussupova; Dinara Utepova; Galiya Orazova; Saule Zhaldybayeva; Galina Skvirskaya; Kanat Tossekbayev
Journal:  Antibiotics (Basel)       Date:  2021-01-08

4.  Implementation of virtual clinical pharmacy services by incorporating medical professionals and pharmacy students: A novel patient-oriented system to advance healthcare in India.

Authors:  Mohammed Salim Karattuthodi; Shabeer Ali Thorakkattil; Ajmal Karumbaru Kuzhiyil; Dilip Chandrasekhar; Khyathi N Bhojak
Journal:  Explor Res Clin Soc Pharm       Date:  2022-03-17

5.  Factors hindering the implementation of clinical pharmacy practice in Egyptian hospitals.

Authors:  Mohamed Kamal Eldin; Marwan Mohyeldin; Gehad Amgad Zaytoun; Mahmoud Abo Elmaaty; Mahmoud Hamza; Sally Fikry; Sherif Kamal; Amani E Khalifa; Sherif Abouelnaga
Journal:  Pharm Pract (Granada)       Date:  2022-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.